Specialist telehealth for EDS, POTS & MCAS
Care that starts where others stop.
Expert, proactive virtual care for Ehlers-Danlos Syndrome and related conditions – a patient-led care model built on evidence, safety, and trust. You know your body.
94% of hEDS patients were previously misdiagnosed with a psychiatric condition. We know. We start from there.
- EDS-specialist clinicians
- Medication safety reviewed for mast cell reactivity
- No waitlist black holes
- You drive your care plan
- Proactive, not reactive protocols
- Transparent pricing
The reality
The system was not built for you.
These numbers aren't statistics to us. They're the reason we exist.
22years
average diagnostic delay for hEDS.
Most patients see 15 or more clinicians before receiving a correct diagnosis. Many are told it's anxiety.
94%
misdiagnosed with a psychiatric condition first.
88% were told they were "making it up." We believe the opposite: you are the expert on your own body.
0
standard drug interaction checkers flag mast-cell triggers.
Every prescription carries risk most doctors don't see. Our safety review layer is built for your biology, not a textbook patient.
Stats sourced from: 2024–2025 global hEDS patient survey (n≈4,000); Yao et al. 2025 Autonomic Neuroscience study; community prevalence data.
The model
How Izara works.
Designed around how complex illness actually works.
Tell us your story – once
A comprehensive intake built for your conditions. Your medication history, your reactions, your current symptoms. Our rigorous diagnostic assessments. Reviewed by a clinician before your first visit, not during it.
We read your history in full so you don't have to re-explain it from scratch at every appointment. You'll never start over with us.
Safety review before anything else
Your full medication and supplement stack is reviewed through our mast-cell-aware safety model. What standard drug checkers miss, we flag.
Including inactive ingredients, dyes, excipients, and histamine liberators that most prescribers don't know to check.
A proactive care plan – yours to navigate
Not a reactive visit every few months. A living care plan that combines clinical treatment, evidence-based lifestyle protocols, and your own expertise.
High-agency means you understand every decision. We explain our reasoning. You push back. We adjust. This is collaborative care.
Continuity. Not starting over.
Every interaction builds on the last. Your care team knows your history. Follow-up is built into the model, not an afterthought.
Izara patients never hear "I don't have your records" or "who referred you again?" We keep the thread.
Smarter with every patient
Your data stays yours. What we learn helps everyone like you.
Every Izara patient is, in a sense, running an experiment. What medications help. What triggers flares. What combinations are dangerous that no drug checker has ever flagged.
We aggregate those signals – anonymously, with your consent – into a shared intelligence layer. Over time, that means we can tell you not just what the research says, but what people with your specific phenotype, your medication stack, and your symptom pattern have actually experienced.
Not "people with EDS." People like you.
This is what moves care from educated guessing to real pattern recognition – and it's something no single specialist, however expert, can offer alone.
Our commitments
What trust-centered care looks like.
We've experienced the alternative first hand and built an antidote care model.
Proactive, not reactive
Standard care waits for a crisis, then responds. Izara operates ahead of it – with structured check-ins, medication reviews triggered by life events, and protocols that anticipate flares rather than only treat them.
High agency by design
You already know more about your symptoms than most doctors you've seen. We don't only manage your care for you – we give you the tools, the knowledge, and the clinical backup to get a clear diagnosis and navigate it with support, on your terms.
Built to become affordable
We're launching without insurance initially. Our roadmap toward broader access is real and public – we believe specialist care for complex chronic illness should not be a luxury.
Initial services
Where we start.
Ehlers-Danlos Syndrome
hEDS, HSD, and the full trifecta of EDS + POTS + MCAS. Diagnosis support, ongoing management, medication safety review, and specialist coordination – all from home.
Medication Safety Portal
A standalone tool for scanning your current medication and supplement stack through our mast-cell-aware safety model. For patients and for providers who want to check before prescribing.
Long COVID
For patients with post-infection mast cell involvement, dysautonomia, and the overlapping symptom profile that most providers still don't recognize. Tell us to notify you.
Patient voice
"I spent twelve years being told my symptoms were anxiety. In my first appointment I was believed, evaluated properly, and had a plan. That's not a small thing. That's everything."
This is a representative account based on patient feedback. Individual results vary.
Early access
You've waited long enough.
Join the waitlist. We respond to every submission. No black holes.
No spam. No upsells. Just a real response within 48 hours.